Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000261895

Medchemexpress LLC Met kinase-IN-2 | 2101241-90-9 | 98.4% | C33H27FN4O4 | 10MG
SDP

Catalog No. 5000261895
Encompass_Preferred

MET kinase-IN-2 is a potent, selective, orally bioavailable inhibitor of the MET (c-Met/HGFR) receptor tyrosine kinase. It inhibits MET with an IC50 of 7.4 nM, shows antitumor activity in cell-based assays, and has reported activity against several additional kinases and tumor cell lines. Supplied as a solid research chemical for laboratory use.

  • Potent MET kinase inhibition (IC50 = 7.4 nM).
  • Orally bioavailable, enabling in vivo studies.
  • Demonstrated antitumor activity in cell assays.
  • Shows additional kinase activity at higher concentrations.
  • High-purity solid suitable for research applications.

Catalog No. 50-002-61895 Supplier Medchemexpress LLC Supplier No. HY13106510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

MET kinase-IN-2 is a potent, selective, orally bioavailable inhibitor of the MET (c-Met/HGFR) receptor tyrosine kinase. It inhibits MET with an IC50 of 7.4 nM, shows antitumor activity in cell-based assays, and has reported activity against several additional kinases and tumor cell lines. Supplied as a solid research chemical for laboratory use.

  • Potent MET kinase inhibition (IC50 = 7.4 nM).
  • Orally bioavailable, enabling in vivo studies.
  • Demonstrated antitumor activity in cell assays.
  • Shows additional kinase activity at higher concentrations.
  • High-purity solid suitable for research applications.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.